Literature DB >> 15471952

Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines.

Carol Beadling1, Mark K Slifka.   

Abstract

Robust CD8(+) T-cell activation is vital for the recovery from many viral infections and is orchestrated via the integration of signals delivered through surface molecules, including the T-cell antigen receptors (TcRs) and cytokine receptors. Little is known about how virus-specific T cells interpret sequential or combined stimulation through these receptors, which must undoubtedly occur in vivo during antiviral immune responses. When measured in real time, peptide antigen and the cytokines, interleukin 12 (IL-12) and IL-18, independently regulate the on/off kinetics of protective (interferon gamma, tumor necrosis factor alpha) and immunomodulatory (IL-2, CD40L) cytokine production by activated T cells and memory T cells. The remarkable differences in effector functions elicited by innate or adaptive signals (IL-12/ IL-18 or peptide, respectively) illustrate the complex and stringent regulation of cytokine expression by CD8(+) T cells. Together, these results indicate how antiviral T cells incorporate multiple signals from their local microenvironment and tailor their cytokine responses accordingly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471952     DOI: 10.1182/blood-2004-07-2833

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Regulation of innate CD8+ T-cell activation mediated by cytokines.

Authors:  Bailey E Freeman; Erika Hammarlund; Hans-Peter Raué; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.

Authors:  M A Rochat; E Schlaepfer; R F Speck
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Cytokine-Mediated Activation of NK Cells during Viral Infection.

Authors:  Bailey E Freeman; Hans-Peter Raué; Ann B Hill; Mark K Slifka
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells.

Authors:  Hope O'Donnell; Oanh H Pham; Lin-xi Li; Shaikh M Atif; Seung-Joo Lee; Marietta M Ravesloot; Jessica L Stolfi; Sean-Paul Nuccio; Petr Broz; Denise M Monack; Andreas J Baumler; Stephen J McSorley
Journal:  Immunity       Date:  2014-02-06       Impact factor: 31.745

Review 5.  Control of memory CD8+ T cell longevity and effector functions by IL-15.

Authors:  Jeffrey C Nolz; Martin J Richer
Journal:  Mol Immunol       Date:  2019-12-06       Impact factor: 4.407

6.  IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing.

Authors:  Matthias Braun; Marie L Ress; Young-Eun Yoo; Claus J Scholz; Matthias Eyrich; Paul G Schlegel; Matthias Wölfl
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

7.  Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.

Authors:  Tobias M Nowacki; Stefanie Kuerten; Wenji Zhang; Carey L Shive; Christian R Kreher; Bernhard O Boehm; Paul V Lehmann; Magdalena Tary-Lehmann
Journal:  Cell Immunol       Date:  2007-09-07       Impact factor: 4.868

Review 8.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

9.  Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions.

Authors:  Bailey E Freeman; Christine Meyer; Mark K Slifka
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

10.  Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner.

Authors:  Yoshinobu Koguchi; Timothy J Thauland; Mark K Slifka; David C Parker
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.